Prohibits drug manufacturers from restricting use of contract pharmacies by 340B covered entities in Hawaii.
This bill aims to preserve the integrity of the federal 340B drug pricing program in Hawaii by prohibiting drug manufacturers and wholesale distributors from limiting access to 340B drugs by pharmacies contracted with 340B covered entities. The 340B program requires drug manufacturers to offer significant discounts on outpatient medications to eligible hospitals and health centers, which reinvest savings into essential community benefits.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.